Solasodine suppresses nasopharyngeal carcinoma progression by inducing ferroptosis

Jing Wang1,2,3, DongHua Wang4, SiQing Ma5

  • 1Hunan Provincial Key Laboratory of the Traditional Chinese Medicine Agricultural Biogenomics, Changsha Medical University, Changsha, 410219, China.

Scientific Reports
|May 18, 2025
PubMed

Insights

Solasodine, a natural compound, effectively inhibits nasopharyngeal carcinoma (NPC) growth by inducing ferroptosis, a specific cell death pathway. This discovery offers a potential new treatment strategy for NPC, requiring further clinical investigation.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in China.
  • Solasodine, a natural compound, shows anticancer potential but its mechanism in NPC is unknown.

Purpose of the Study:

  • To investigate the efficacy and mechanism of solasodine in treating nasopharyngeal carcinoma.
  • To identify the molecular targets and cell death pathways involved in solasodine's action.

Main Methods:

  • In vitro and in vivo experiments to assess solasodine's effect on NPC.
  • Network pharmacology to identify solasodine's molecular targets.
  • Analysis of ferroptosis hallmarks and related proteins.

Main Results:

  • Solasodine significantly suppressed NPC growth and induced cell death.
  • Network pharmacology identified HMOX1 as a key target, linking solasodine to ferroptosis.
  • Solasodine triggered ferroptosis, evidenced by mitochondrial changes, altered iron/ROS/MDA levels, GSH depletion, and specific protein dysregulation. Ferroptosis inhibitors rescued cell death.

Conclusions:

  • Solasodine acts as a novel ferroptosis inducer for nasopharyngeal carcinoma treatment.
  • The study highlights solasodine's therapeutic potential, warranting further validation in patient-derived models and clinical trials.